lorazepam has been researched along with methoxyhydroxyphenylglycol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demisch, L; Eckert, J; Gille, B; Northoff, G; Pflug, B; Wenke, J | 1 |
| Greenblatt, DJ; Hashim, A; Lajtha, A; Pomara, N; Sershen, H; Sidtis, JJ; Wesnes, K; Willoughby, LM | 1 |
2 trial(s) available for lorazepam and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Lorazepam; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia | 1995 |
Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype.
Topics: Aged; Analysis of Variance; Anti-Anxiety Agents; Apolipoprotein E4; Apolipoproteins; Apolipoproteins E; Cognition; Cognition Disorders; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lorazepam; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Regression Analysis | 2004 |